Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) |
---|
10/28/2004 | US20040214896 drugs and/or prodrugs such as N-hydroxy-6-(4-(4-chlorophenyl)phenyl)-6-hydroxyhexanamide, used for prophylaxis of inflammatory disorders, cancers, psoriasis, diabetes, autoimmune diseases, hepatitis, graft versus host disease or endometriosis |
10/28/2004 | US20040214890 1,3-diamino-2-hydroxypropane derivatives are useful as inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal |
10/28/2004 | US20040214888 Carboxylic acid derivative and medicine comprising salt or ester of the same |
10/28/2004 | US20040214880 Antitumor agents, anticarcinogenic agents; inhibitors of histone deacetylase; a methyleneaminooxymethyl)-thiophene-2-carboxylic acid (2-amino-phenyl)-amide derivatives; chemical synthesis |
10/28/2004 | US20040214869 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
10/28/2004 | US20040214862 A N'-hydroxy-terephthalamide derivatives; histone deacetylase enzyme inhibitors; ANTIPROLIFERATIVE AGENTS; ANTITUMOR AGENTS |
10/28/2004 | US20040214827 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants |
10/28/2004 | US20040214822 Substituted 4-aminocyclohexanol compounds |
10/28/2004 | CA2527170A1 Therapeutic compounds |
10/28/2004 | CA2522118A1 Compounds that modulate ppar activity and methods of preparation |
10/28/2004 | CA2521937A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
10/28/2004 | CA2517155A1 Fluoro-and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof |
10/27/2004 | EP1471064A1 Coumarin derivatives, process for their production and use thereof |
10/27/2004 | EP1471054A1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
10/27/2004 | EP1470752A1 Insecticides containing hydrazone derivatives as the active ingredient and novel hydrazone derivatives |
10/27/2004 | EP1470102A1 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases (ptps) |
10/27/2004 | EP1470100A1 Triarylamine derivatives and the use thereof in organic electroluminescent and electrophotographic devices |
10/27/2004 | EP1404687A4 Fluorous triphase and other multiphase systems |
10/27/2004 | EP1272456B1 Hydrazide and alkoxyamide angiogenesis inhibitors |
10/27/2004 | EP0960108B1 Matrix metalloproteinase inhibitors |
10/27/2004 | CN1541214A Novel compounds |
10/27/2004 | CN1541211A Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same |
10/27/2004 | CN1539836A Processes for prodn. of thienopyrimidine derivatives |
10/27/2004 | CN1539816A IL-8 receptor antagonist |
10/26/2004 | US6809207 Amino acid derivatives |
10/26/2004 | US6809100 Hydroxamic acid derivatives |
10/26/2004 | US6809090 Nitrogen monoxide synthase and/or lipidic peroxidation inhibitors |
10/26/2004 | US6809089 Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators |
10/26/2004 | US6809088 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
10/26/2004 | CA2224155C 1-(2-deoxy-2-fluoro-4-thio-beta-d-arabinofuranosyl)cytosine |
10/26/2004 | CA2023811C Process and intermediates for preparing compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity |
10/21/2004 | WO2004089929A1 5-amino-2-carbonylthiophene derivatives for use as p38 map kinase inhibitors in the treatment of inflammatory diseases |
10/21/2004 | WO2004089918A1 Heteroaromatic pentacyclic compound and medicinal use thereof |
10/21/2004 | WO2004089885A1 Novel compounds |
10/21/2004 | WO2004089882A2 Aromatic sulfonamides as peroxynitrite-rearrangement catalysts |
10/21/2004 | WO2004089881A1 New sulfonyl derivatives of aminonaphtols |
10/21/2004 | WO2004089877A1 New hydroxynaphthyl amides |
10/21/2004 | WO2004089360A1 Polyamine compounds for treating chemokine receptor mediated diseases |
10/21/2004 | US20040209943 e.g., N-(3-Cyano-4,5-dimethyl-thiophen-2-yl)-2,2-diphenyl-acetamide;3-Methyl-2-phenyl-pentanoic acid-(3-cyano-5,6-dihydro-4H-cyclopenta[b]thiophen-2-yl)-amide; or N-(3-Cyano-6-methanesulfonyl-4,5,6,7-tetrahydro-thieno [2,3-c]pyridin-2-yl)-2,2-diphenyl-acetamide; |
10/21/2004 | US20040209936 Compounds that modulate PPAR activity and methods of preparation |
10/21/2004 | US20040209865 use for reducing body weight and treating urinary incontinence; Melanin-concentrating hormone (MCH); 5-(4-chloro-phenyl)-2-[5-(2-pyrrolidin-1-yl-ethoxy)-pyridin-2-yl-ethynyl]-pyridine for example |
10/21/2004 | US20040209846 Heterocyclic analgesic compounds and methods of use thereof |
10/21/2004 | US20040209186 oxime sulfonates, e.g., 2-[Cyano-(5-n-propanesulfonyloxyimino-5H-thiophen-2-ylidene)-methyl]-benzoic acid methyl ester with high stability and good solubility in the field of chemically amplified photoresists. |
10/21/2004 | US20040205908 Primary intermediates for oxidative coloration of hair |
10/21/2004 | CA2521830A1 Heteroaromatic pentacyclic compound and medicinal use thereof |
10/21/2004 | CA2521653A1 Aromatic sulfonamides as peroxynitrite-rearrangement catalysts |
10/21/2004 | CA2521416A1 Polyamine compounds for treating chemokine receptor mediated diseases |
10/20/2004 | EP1467978A1 Pancreatic lipase inhibitor compounds, their synthesis and use |
10/20/2004 | EP1467723A1 Phenyl sulfoxides and phenyl sulfones |
10/20/2004 | EP1443045A9 Carbanilide used as pesticide |
10/20/2004 | EP1206473B1 Isomeric fused pyrrolocarbazoles and isoindolones |
10/20/2004 | CN1538955A Pyrrolidine derivatives as factor Xa inhibitors |
10/20/2004 | CN1537850A New use of Ziegler-type homogeneous catalyst |
10/20/2004 | CN1171883C Nonsteroidal antiinflammatories |
10/20/2004 | CN1171863C Carbamate derivatives and agricultural/horticulatrual bactericides |
10/20/2004 | CN1171861C Halogenated amidino amino acid dervatives useful as nitric oxide synthase inhibitors |
10/20/2004 | CN1171859C Fungicide and insecticide benzyloxycyclopropyl substituted aromatic compound fungicide |
10/19/2004 | US6806378 Catalyst system and a process for the preparation of a nonracemic chiral alcohol by hydrogenation of a ketone using the catalyst system, wherein the catalyst system comprises ruthenium, a nonracemic chiral diphosphine ligand, an |
10/19/2004 | US6806374 Field effect transistor, oled, electroluminescent device, rfid tag, backlight, photovoltaic or sensor device, or electrophotographic recording device; security marking; charge injection layer, planarising layer, antistatic film |
10/19/2004 | US6806264 Arylphenyl-substituted cyclic ketoenols |
10/19/2004 | US6806024 Oxime derivatives and the use thereof as photoinitiators |
10/14/2004 | WO2004088312A2 Fluorescently tagged ligands |
10/14/2004 | WO2004087693A1 Oxime derivatives and their use as pharmaceutically active agents |
10/14/2004 | WO2004087061A2 Tubulin binding agents and corresponding prodrug constructs |
10/14/2004 | WO2004056727A3 Process of making chalcone derivatives |
10/14/2004 | WO2004029046A3 Novel raloxifene acid addition salts and/or solvates thereof, improved method for purification of said raloxifene acid addition salts and/or solvates thereof and pharmaceutical compositions comprising these |
10/14/2004 | WO2004024939A3 Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof |
10/14/2004 | US20040204597 Method for preparing ruthenium-carrying alumina and method for oxidizing alcohol |
10/14/2004 | US20040204502 Such as 4-(4-(3-hydroxy-3-methyl-butane-1-sulfinylmethyl)-phenylmethanesulfinyl)-2 -methyl-butan1-ol for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders |
10/14/2004 | US20040204477 For use as antiproliferative agents |
10/14/2004 | US20040204452 to decompose peroxynitrite anion into harmless nitrate or nitrite endproducts which prevents the free radical-mediated cell damage; cytoprotective; Alzheimer's disease; 3,5-dimethylisoxazole-4-sulfonic acid 4-pyrrolidin-1-ylphenylamide |
10/14/2004 | CA2521113A1 Fluorescently tagged ligands |
10/14/2004 | CA2519301A1 Oxime derivatives and their use as pharmaceutically active agents |
10/13/2004 | EP1466898A1 Beta-amyloid protein production/secretion inhibitors |
10/13/2004 | EP1466891A1 Carboxylic acid derivative |
10/13/2004 | EP1466625A1 Preventives/remedies for urinary disturbance |
10/13/2004 | EP1465892A1 Glycinamides as factor xa inhibitors |
10/13/2004 | EP1465867A1 Ligands of melanocortin receptors and compositions and methods related thereto |
10/13/2004 | EP1465861A1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors |
10/13/2004 | EP1465854A2 Chalcone derivatives and their use to treat diseases |
10/13/2004 | EP1465726A1 Process for preparing nonracemic chiral alcohols |
10/13/2004 | EP1465638A2 Phosphate transport inhibitors |
10/13/2004 | EP1465623A1 Urea derivatives |
10/13/2004 | EP1322309A4 High affinity small molecule c5a receptor modulators |
10/13/2004 | EP1107745B1 Use of 5ht-6 antagonists for the treatment of adhd |
10/13/2004 | EP0736036B1 Kininogen inhibitors |
10/13/2004 | CN1537100A Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives |
10/13/2004 | CN1537093A Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc. |
10/13/2004 | CN1536992A Carbamates of 2-heterocyclic-1, 2-ethanediols |
10/13/2004 | CN1535963A Conductive compound, electrode and sensor contain said conductive compound and method for detecting target molecule by using sad sensor |
10/13/2004 | CN1535956A Substituted phenyl keto-enol pesticide and weedicide |
10/13/2004 | CN1170813C N2 phenylamidine derivatives and fungicidal composition and use |
10/12/2004 | US6803388 Treating atherosclerosis and coronary artery diseases; stereoselective; chemical intermediates |
10/12/2004 | US6803384 Diaminopropionic acid derivatives |
10/12/2004 | US6803381 Carbamic acid derivatives |
10/12/2004 | US6803378 For therapy and prophylaxis of acquired immune deficiency syndrome (aids), or arc |
10/12/2004 | CA2170394C Process for conditioning substances |
10/07/2004 | WO2004085421A2 Bioreductively-activated prodrugs |
10/07/2004 | WO2004085420A1 Bicyclic compounds useful as angiotensin ii agonists |
10/07/2004 | WO2004085419A1 Trifluoromethyl-thiophene carboxylic acid anilides and use thereof as fungicides |